Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Other Accumulated Expenses (2016 - 2020)

Historic Other Accumulated Expenses for Phio Pharmaceuticals (PHIO) over the last 8 years, with Q4 2020 value amounting to $104000.0.

  • Phio Pharmaceuticals' Other Accumulated Expenses rose 28518.52% to $104000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $104000.0, marking a year-over-year increase of 28518.52%. This contributed to the annual value of $104000.0 for FY2020, which is 28518.52% up from last year.
  • Latest data reveals that Phio Pharmaceuticals reported Other Accumulated Expenses of $104000.0 as of Q4 2020, which was up 28518.52% from $27000.0 recorded in Q4 2019.
  • In the past 5 years, Phio Pharmaceuticals' Other Accumulated Expenses ranged from a high of $104000.0 in Q4 2020 and a low of $8000.0 during Q4 2017
  • Moreover, its 4-year median value for Other Accumulated Expenses was $18500.0 (2016), whereas its average is $37250.0.
  • As far as peak fluctuations go, Phio Pharmaceuticals' Other Accumulated Expenses crashed by 2000.0% in 2017, and later surged by 28518.52% in 2020.
  • Quarter analysis of 4 years shows Phio Pharmaceuticals' Other Accumulated Expenses stood at $10000.0 in 2016, then dropped by 20.0% to $8000.0 in 2017, then soared by 237.5% to $27000.0 in 2019, then soared by 285.19% to $104000.0 in 2020.
  • Its Other Accumulated Expenses stands at $104000.0 for Q4 2020, versus $27000.0 for Q4 2019 and $8000.0 for Q4 2017.